Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Digital Pharma: Searching for clinical trials

February 23, 2010 Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment

A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …
Feature

Chiltern Announces Partnership with Charles River

February 23, 2010 Research and Development

News
Press release

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010 Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Appointment
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010 Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …
News

ReNeuron to begin landmark stem cell trial for stroke

February 19, 2010 Research and Development ReNeuron, stem cell

ReNeuron has been given the go-ahead to begin clinical trials of the first ever stem cell therapy for patients disabled …
News

Clinipace appoints Bud Owen and Daryl Porter

February 19, 2010 Research and Development Clinipace, appointment, research and development

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …
Appointment

Dr Jay Feingold joins Daiichi Sankyo

February 19, 2010 Research and Development Daiichi Sankyo, appointment, research and development

Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …
Appointment

Merck’s HIV treatment fails in phase III

February 18, 2010 Research and Development HIV, Merck

Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …
News
Money trap

Drug development: where’s the added investment value?

February 18, 2010 Research and Development CRO, Les Rose, R&D, biotech, funding

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …
Feature

Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission

February 18, 2010 Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing

Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …
Appointment

Chiltern Opens New Office In Argentina

February 17, 2010 Research and Development

Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. “Our office, strategically located in suburban Pilar, is a natural …
News
Press release

PolyTherics raises £3m to fund PEG expansion

February 17, 2010 Manufacturing and Production, Research and Development PolyTherics, biotech, pegylation

UK drug delivery specialist PolyTherics has raised an additional £3 million in funding as it extends the focus of its …
News

AstraZeneca signs deal with Rigel on RA treatment

February 17, 2010 Research and Development AZ, Rigel, rheumatoid arthritis

AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …
News

Dr Steven Leventer to head up neuroscience research for PharmaNet

February 17, 2010 Research and Development PharmaNet, appointment, research and development

PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …
Appointment
immaticslogoJPG72dpi

Immatics vaccine trials to be conducted with Cancer Research UK

February 16, 2010 Research and Development immatics, vaccines

Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026